KSC:003090
Daewoong Co., Ltd. · KSC · Healthcare · KRW · FY for 2025
Figures on this page computed 2026-11-08 11:04 UTC
Last close
n/aKRW
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
3.8xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
8.5%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
-1.8%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
0.9%Dividend yield
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
What it pays out is the furthest below its sector's middle: 0.39 against 0.44 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales1.37x
Its own average over 10 years, 1.51T.
- Profit2.08x
Its own average over 10 years, 84.37B.
- Free cash flow2.23x
Its own average over 10 years, -16.72B.
- Debt1.78x
Its own average over 10 years, 492.23B.
- Pricen/a
Its own average over 0 years. Market data
Free cash flow is furthest from its own average, at 2.23 times.
The filed years, as a table
10Each line is 100 at 2016-12-31, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2016-12-31 | 100.0 | 100.0 | 100.0 |
| 2017-12-31 | 110.7 | 334.1 | 100.2 |
| 2018-12-31 | 121.3 | 150.6 | 100.2 |
| 2019-12-31 | 134.5 | 314.9 | 100.2 |
| 2020-12-31 | 133.5 | 496.1 | 97.4 |
| 2021-12-31 | 148.9 | 397.0 | 96.4 |
| 2022-12-31 | 167.2 | 517.2 | 96.5 |
| 2023-12-31 | 178.8 | 769.8 | 96.0 |
| 2024-12-31 | 190.8 | 291.9 | 94.9 |
| 2025-12-31 | 203.8 | 882.8 | 134.9 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
How profit was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Figures behind the shape
Growth
8.8%faster is higher, placed against 4,950 companies as of 2026-11-07
Five-year revenue growth rate8.8%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
Five-year EPS growth rate12.8%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
One-year change in net income202.4%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
Returns on capital
14.9%higher is higher, placed against 5,089 companies as of 2026-11-07
Return on invested capitaln/a
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity14.9%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets5.4%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Margins
52.7%wider is higher, placed against 3,412 companies as of 2026-11-07
Gross margin52.7%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin12.6%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin8.5%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin-1.8%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Price
3.8xcheaper is higher, placed against 4,362 companies as of 2026-11-07
Price to earnings3.8x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
- Computed from the filing for 2025
Price to book0.8x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDAn/a
We do not hold this figure for this company, so there is nothing to place.
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio0.5x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
Safety
1.34safer is higher, placed against 3,227 companies as of 2026-11-07
Debt to equityn/a
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio1.34
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coverage18.8x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Score1.70
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
What it pays out
0.9%more, and better covered, is higher, placed against 1,091 companies as of 2026-11-07
Dividend yield0.9%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
Payout ratio4.7%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ratio-4.5x
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.